Biomerica, Inc. (BMRA)
USD 0.51
(-4.89%)
USD 0.51
(-4.89%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 | 2.37 Million USD | 15.56% |
| 2023 | 2.05 Million USD | -14.9% |
| 2022 | 2.41 Million USD | -24.64% |
| 2021 | 3.2 Million USD | 12.46% |
| 2020 | 2.85 Million USD | 32.53% |
| 2019 | 2.15 Million USD | -1.27% |
| 2018 | 2.17 Million USD | 26.0% |
| 2017 | 1.72 Million USD | -7.19% |
| 2016 | 1.86 Million USD | -8.1% |
| 2015 | 2.02 Million USD | 14.82% |
| 2014 | 1.76 Million USD | 12.38% |
| 2013 | 1.57 Million USD | -13.72% |
| 2012 | 1.82 Million USD | 1.99% |
| 2011 | 1.78 Million USD | -0.28% |
| 2010 | 1.79 Million USD | -10.45% |
| 2009 | 1.99 Million USD | 13.34% |
| 2008 | 1.76 Million USD | 20.69% |
| 2007 | 1.46 Million USD | 32.36% |
| 2006 | 1.1 Million USD | -47.16% |
| 2005 | 2.09 Million USD | -21.8% |
| 2004 | 2.67 Million USD | 0.86% |
| 2003 | 2.64 Million USD | -9.28% |
| 2002 | 2.92 Million USD | 1.92% |
| 2001 | 2.86 Million USD | 0.2% |
| 2000 | 2.86 Million USD | -7.73% |
| 1999 | 3.1 Million USD | 24.0% |
| 1998 | 2.5 Million USD | 4.17% |
| 1997 | 2.4 Million USD | 14.29% |
| 1996 | 2.1 Million USD | 16.67% |
| 1995 | 1.8 Million USD | 12.5% |
| 1994 | 1.6 Million USD | -27.27% |
| 1993 | 2.2 Million USD | -4.35% |
| 1992 | 2.3 Million USD | 4.55% |
| 1991 | 2.2 Million USD | -21.43% |
| 1990 | 2.8 Million USD | 600.0% |
| 1989 | 400 Thousand USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 FY | 2.37 Million USD | 15.56% |
| 2024 Q4 | 2.37 Million USD | 11.6% |
| 2024 Q3 | 2.12 Million USD | 15.64% |
| 2024 Q1 | 1.87 Million USD | -8.71% |
| 2024 Q2 | 1.84 Million USD | -1.92% |
| 2023 Q2 | 2.06 Million USD | 7.23% |
| 2023 Q1 | 1.92 Million USD | -20.45% |
| 2023 FY | 2.05 Million USD | -14.9% |
| 2023 Q4 | 2.05 Million USD | -0.39% |
| 2023 Q3 | 2.06 Million USD | 0.15% |
| 2022 Q1 | 2.86 Million USD | -10.73% |
| 2022 Q4 | 2.41 Million USD | -25.22% |
| 2022 FY | 2.41 Million USD | -24.64% |
| 2022 Q2 | 2.98 Million USD | 4.19% |
| 2022 Q3 | 3.23 Million USD | 8.35% |
| 2021 Q4 | 3.2 Million USD | 12.1% |
| 2021 FY | 3.2 Million USD | 12.46% |
| 2021 Q1 | 4.1 Million USD | 43.85% |
| 2021 Q2 | 4.19 Million USD | 2.37% |
| 2021 Q3 | 2.86 Million USD | -31.87% |
| 2020 FY | 2.85 Million USD | 32.53% |
| 2020 Q1 | 2.2 Million USD | 2.57% |
| 2020 Q2 | 2.19 Million USD | -0.7% |
| 2020 Q3 | 2.18 Million USD | -0.15% |
| 2020 Q4 | 2.85 Million USD | 30.32% |
| 2019 Q1 | 2.2 Million USD | 1.34% |
| 2019 Q3 | 2.08 Million USD | -1.64% |
| 2019 FY | 2.15 Million USD | -1.27% |
| 2019 Q4 | 2.15 Million USD | 3.4% |
| 2019 Q2 | 2.11 Million USD | -4.21% |
| 2018 Q1 | 1.79 Million USD | 3.61% |
| 2018 Q4 | 2.17 Million USD | 11.52% |
| 2018 Q3 | 1.95 Million USD | 6.95% |
| 2018 Q2 | 1.82 Million USD | 1.96% |
| 2018 FY | 2.17 Million USD | 26.0% |
| 2017 Q4 | 1.72 Million USD | -4.9% |
| 2017 FY | 1.72 Million USD | -7.19% |
| 2017 Q1 | 1.85 Million USD | -0.68% |
| 2017 Q2 | 1.88 Million USD | 1.66% |
| 2017 Q3 | 1.81 Million USD | -3.34% |
| 2016 Q4 | 1.86 Million USD | -11.29% |
| 2016 Q3 | 2.1 Million USD | -6.14% |
| 2016 Q2 | 2.23 Million USD | 6.08% |
| 2016 FY | 1.86 Million USD | -8.1% |
| 2016 Q1 | 2.1 Million USD | 4.03% |
| 2015 FY | 2.02 Million USD | 14.82% |
| 2015 Q2 | 1.98 Million USD | 5.84% |
| 2015 Q4 | 2.02 Million USD | -3.95% |
| 2015 Q3 | 2.11 Million USD | 6.07% |
| 2015 Q1 | 1.88 Million USD | 6.48% |
| 2014 FY | 1.76 Million USD | 12.38% |
| 2014 Q4 | 1.76 Million USD | -8.9% |
| 2014 Q2 | 1.89 Million USD | 6.04% |
| 2014 Q1 | 1.79 Million USD | 14.02% |
| 2014 Q3 | 1.93 Million USD | 2.04% |
| 2013 Q2 | 1.8 Million USD | -1.13% |
| 2013 Q1 | 1.82 Million USD | -0.02% |
| 2013 FY | 1.57 Million USD | -13.72% |
| 2013 Q4 | 1.57 Million USD | -7.86% |
| 2013 Q3 | 1.7 Million USD | -5.27% |
| 2012 Q3 | 1.86 Million USD | 11.55% |
| 2012 Q1 | 1.73 Million USD | -2.83% |
| 2012 FY | 1.82 Million USD | 1.99% |
| 2012 Q2 | 1.66 Million USD | -3.79% |
| 2012 Q4 | 1.82 Million USD | -2.2% |
| 2011 FY | 1.78 Million USD | -0.28% |
| 2011 Q1 | 1.87 Million USD | 4.79% |
| 2011 Q2 | 1.81 Million USD | -3.27% |
| 2011 Q3 | 1.83 Million USD | 1.12% |
| 2011 Q4 | 1.78 Million USD | -2.71% |
| 2010 Q2 | 1.94 Million USD | -5.32% |
| 2010 Q1 | 2.05 Million USD | 2.91% |
| 2010 FY | 1.79 Million USD | -10.45% |
| 2010 Q3 | 1.95 Million USD | 0.49% |
| 2010 Q4 | 1.79 Million USD | -8.54% |
| 2009 Q1 | 1.95 Million USD | 10.79% |
| 2009 Q4 | 1.99 Million USD | -3.96% |
| 2009 FY | 1.99 Million USD | 13.34% |
| 2009 Q2 | 1.99 Million USD | 1.98% |
| 2009 Q3 | 2.08 Million USD | 4.46% |
| 2008 Q2 | 1.66 Million USD | 15.7% |
| 2008 Q3 | 1.67 Million USD | 0.61% |
| 2008 Q4 | 1.76 Million USD | 5.06% |
| 2008 FY | 1.76 Million USD | 20.69% |
| 2008 Q1 | 1.44 Million USD | -1.31% |
| 2007 Q2 | 1.21 Million USD | 3.7% |
| 2007 Q4 | 1.46 Million USD | 3.59% |
| 2007 Q1 | 1.17 Million USD | 6.03% |
| 2007 FY | 1.46 Million USD | 32.36% |
| 2007 Q3 | 1.41 Million USD | 16.2% |
| 2006 Q4 | 1.1 Million USD | -5.35% |
| 2006 Q1 | 2.24 Million USD | 7.59% |
| 2006 Q2 | 2.35 Million USD | 4.59% |
| 2006 Q3 | 1.16 Million USD | -50.39% |
| 2006 FY | 1.1 Million USD | -47.16% |
| 2005 Q3 | 2.83 Million USD | -2.68% |
| 2005 FY | 2.09 Million USD | -21.8% |
| 2005 Q2 | 2.91 Million USD | 1.66% |
| 2005 Q1 | 2.86 Million USD | 7.31% |
| 2005 Q4 | 2.09 Million USD | -26.34% |
| 2004 Q3 | 2.63 Million USD | -0.69% |
| 2004 FY | 2.67 Million USD | 0.86% |
| 2004 Q2 | 2.65 Million USD | -2.31% |
| 2004 Q1 | 2.71 Million USD | 2.58% |
| 2004 Q4 | 2.67 Million USD | 1.35% |
| 2003 Q3 | 2.5 Million USD | -7.08% |
| 2003 Q1 | 2.85 Million USD | -2.15% |
| 2003 Q2 | 2.69 Million USD | -5.69% |
| 2003 Q4 | 2.64 Million USD | 5.8% |
| 2003 FY | 2.64 Million USD | -9.28% |
| 2002 Q1 | 2.99 Million USD | 4.42% |
| 2002 Q2 | 2.95 Million USD | -1.31% |
| 2002 Q3 | 2.92 Million USD | -0.98% |
| 2002 Q4 | 2.92 Million USD | -0.12% |
| 2002 FY | 2.92 Million USD | 1.92% |
| 2001 Q2 | 2.95 Million USD | 4.26% |
| 2001 Q4 | 2.86 Million USD | -6.87% |
| 2001 Q3 | 3.07 Million USD | 4.31% |
| 2001 FY | 2.86 Million USD | 0.2% |
| 2001 Q1 | 2.82 Million USD | -1.06% |
| 2000 FY | 2.86 Million USD | -7.73% |
| 2000 Q1 | 3.2 Million USD | 3.23% |
| 2000 Q2 | 3.1 Million USD | -3.13% |
| 2000 Q4 | 2.86 Million USD | -11.4% |
| 2000 Q3 | 3.22 Million USD | 4.14% |
| 1999 Q3 | 3 Million USD | 3.45% |
| 1999 Q4 | 3.1 Million USD | 3.33% |
| 1999 Q2 | 2.9 Million USD | 3.57% |
| 1999 Q1 | 2.8 Million USD | 12.0% |
| 1999 FY | 3.1 Million USD | 24.0% |
| 1998 Q4 | 2.5 Million USD | 4.17% |
| 1998 FY | 2.5 Million USD | 4.17% |
| 1998 Q1 | 2.6 Million USD | 8.33% |
| 1998 Q2 | 2.5 Million USD | -3.85% |
| 1998 Q3 | 2.4 Million USD | -4.0% |
| 1997 Q1 | 2.2 Million USD | 4.76% |
| 1997 FY | 2.4 Million USD | 14.29% |
| 1997 Q4 | 2.4 Million USD | 4.35% |
| 1997 Q3 | 2.3 Million USD | 0.0% |
| 1997 Q2 | 2.3 Million USD | 4.55% |
| 1996 Q1 | 2 Million USD | 11.11% |
| 1996 Q4 | 2.1 Million USD | 0.0% |
| 1996 Q3 | 2.1 Million USD | 0.0% |
| 1996 FY | 2.1 Million USD | 16.67% |
| 1996 Q2 | 2.1 Million USD | 5.0% |
| 1995 Q4 | 1.8 Million USD | 28.57% |
| 1995 FY | 1.8 Million USD | 12.5% |
| 1995 Q2 | 1.5 Million USD | -6.25% |
| 1995 Q3 | 1.4 Million USD | -6.67% |
| 1995 Q1 | 1.6 Million USD | 0.0% |
| 1994 Q1 | 1.9 Million USD | -13.64% |
| 1994 Q2 | 1.8 Million USD | -5.26% |
| 1994 FY | 1.6 Million USD | -27.27% |
| 1994 Q3 | 1.7 Million USD | -5.56% |
| 1994 Q4 | 1.6 Million USD | -5.88% |
| 1993 Q2 | 2.5 Million USD | 4.17% |
| 1993 Q4 | 2.2 Million USD | -12.0% |
| 1993 FY | 2.2 Million USD | -4.35% |
| 1993 Q1 | 2.4 Million USD | 4.35% |
| 1993 Q3 | 2.5 Million USD | 0.0% |
| 1992 Q3 | 2.4 Million USD | -4.0% |
| 1992 Q2 | 2.5 Million USD | 4.17% |
| 1992 Q4 | 2.3 Million USD | -4.17% |
| 1992 FY | 2.3 Million USD | 4.55% |
| 1992 Q1 | 2.4 Million USD | 9.09% |
| 1991 FY | 2.2 Million USD | -21.43% |
| 1991 Q4 | 2.2 Million USD | 0.0% |
| 1991 Q3 | 2.2 Million USD | -18.52% |
| 1991 Q2 | 2.7 Million USD | -10.0% |
| 1991 Q1 | 3 Million USD | 7.14% |
| 1990 Q1 | 300 Thousand USD | -25.0% |
| 1990 Q3 | 300 Thousand USD | 0.0% |
| 1990 Q4 | 2.8 Million USD | 833.33% |
| 1990 FY | 2.8 Million USD | 600.0% |
| 1989 Q4 | 400 Thousand USD | 0.0% |
| 1989 Q3 | 400 Thousand USD | 0.0% |
| 1989 FY | 400 Thousand USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 3.31 Million USD | 28.218% |
| BrainsWay Ltd. | 3.71 Million USD | 36.077% |
| Cerus Corporation | 39.86 Million USD | 94.04% |
| Envoy Medical, Inc. | 1.4 Million USD | -69.231% |
| electroCore, Inc. | 2.16 Million USD | -10.0% |
| Helius Medical Technologies, Inc. | 457 Thousand USD | -419.912% |
| IceCure Medical Ltd | 2.27 Million USD | -4.44% |
| Inogen, Inc. | 21.84 Million USD | 89.121% |
| OrthoPediatrics Corp. | 105.85 Million USD | 97.755% |
| Lucid Diagnostics Inc. | 278 Thousand USD | -754.676% |
| Monogram Orthopaedics, Inc. | 1.00 USD | -237599900.0% |
| MaxCyte, Inc. | 12.22 Million USD | 80.571% |
| NeuroOne Medical Technologies Corporation | 1.72 Million USD | -37.605% |
| Nexalin Technology, Inc. | 156.42 Thousand USD | -1418.987% |
| Orthofix Medical Inc. | 222.16 Million USD | 98.931% |
| PAVmed Inc | 1.01 Million USD | -133.629% |
| Rapid Micro Biosystems, Inc. | 19.96 Million USD | 88.097% |
| RxSight, Inc. | 17.42 Million USD | 86.361% |
| Sight Sciences, Inc. | 7.84 Million USD | 69.729% |
| SI-BONE, Inc. | 20.24 Million USD | 88.266% |
| TELA Bio, Inc. | 13.16 Million USD | 81.948% |
| Treace Medical Concepts, Inc. | 29.24 Million USD | 91.876% |
| Vivos Therapeutics, Inc. | 1.00 USD | -237599900.0% |
| Acutus Medical, Inc. | 4.27 Million USD | 44.46% |
| Talis Biomedical Corporation | - USD | -Infinity% |
| Spectral AI, Inc. | 230 Thousand USD | -933.043% |
| Nano-X Imaging Ltd. | 2.35 Million USD | -0.849% |
| CVRx, Inc. | 10.98 Million USD | 78.367% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 390.07 Thousand USD | -509.112% |
| Bioventus Inc. | 91.33 Million USD | 97.399% |
| Venus Concept Inc. | 28.67 Million USD | 91.714% |
| TriSalus Life Sciences, Inc. | 2.54 Million USD | 6.64% |
| LivaNova PLC | 147.88 Million USD | 98.393% |
| 908 Devices Inc. | 14.93 Million USD | 84.094% |
| Alphatec Holdings, Inc. | 136.84 Million USD | 98.264% |
| Nemaura Medical Inc. | 1.75 Million USD | -35.396% |
| NeuroPace, Inc. | 11.21 Million USD | 78.812% |
| LENSAR, Inc. | 15.68 Million USD | 84.856% |
| Apyx Medical Corporation | 9.92 Million USD | 76.056% |
| Cutera, Inc. | 72.1 Million USD | 96.705% |
| STRATA Skin Sciences, Inc. | 2.67 Million USD | 11.111% |
| BioSig Technologies, Inc. | -103 Thousand USD | 2406.796% |
| Anika Therapeutics, Inc. | 46.38 Million USD | 94.878% |
| ClearPoint Neuro, Inc. | 7.91 Million USD | 69.966% |
| Integra LifeSciences Holdings Corporation | 389.6 Million USD | 99.39% |
| Axonics, Inc. | 79.94 Million USD | 97.028% |
| Outset Medical, Inc. | 49.21 Million USD | 95.172% |
| IRIDEX Corporation | 9.9 Million USD | 76.015% |
| PROCEPT BioRobotics Corporation | 39.75 Million USD | 94.024% |
| IRadimed Corporation | 12.82 Million USD | 81.468% |
| Tivic Health Systems, Inc. | 756 Thousand USD | -214.286% |
| INVO Bioscience, Inc. | 264.5 Thousand USD | -798.275% |
| Telesis Bio, Inc. | 4.02 Million USD | 40.969% |
| Viemed Healthcare, Inc. | 4.6 Million USD | 48.396% |
| Varex Imaging Corporation | 277.5 Million USD | 99.144% |
| Quipt Home Medical Corp. | 18.32 Million USD | 87.035% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 16.74 Million USD | 85.809% |
| Dynatronics Corporation | 5.59 Million USD | 57.526% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 3.74 Million USD | 36.488% |
| Semler Scientific, Inc. | 445 Thousand USD | -433.933% |
| InMode Ltd. | 45.09 Million USD | 94.731% |
| Bruker Corporation | 968.3 Million USD | 99.755% |
| Cytosorbents Corporation | 3.68 Million USD | 35.437% |
| DexCom, Inc. | 559.6 Million USD | 99.575% |
| Align Technology, Inc. | 296.9 Million USD | 99.2% |
| Viveve Medical, Inc. | 1.47 Million USD | -61.413% |
| ZimVie Inc. | 79.6 Million USD | 97.015% |
| Movano Inc. | 1.51 Million USD | -57.039% |
| Cytek Biosciences, Inc. | 60.87 Million USD | 96.097% |
| Nexalin Technology, Inc. | 156.42 Thousand USD | -1418.987% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 157.93 Million USD | 98.496% |
| Profound Medical Corp. | 6.95 Million USD | 65.829% |
| Insulet Corporation | 402.6 Million USD | 99.41% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 14.83 Million USD | 83.988% |
| iCAD, Inc. | 917 Thousand USD | -159.106% |
| Nuwellis, Inc. | 1.99 Million USD | -18.978% |
| Biotricity, Inc. | 1.87 Million USD | -26.423% |
| iRhythm Technologies, Inc. | 13.97 Million USD | 82.996% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 2.1 Million USD | -12.821% |
| PAVmed Inc. | 1.01 Million USD | -133.629% |
| BIOLASE, Inc. | 11.43 Million USD | 79.218% |
| Beyond Air, Inc. | 2.12 Million USD | -11.707% |
| FONAR Corporation | 2.71 Million USD | 12.5% |
| AxoGen, Inc. | 23.02 Million USD | 89.679% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 22.52 Million USD | 89.453% |
| Inari Medical, Inc. | 42.9 Million USD | 94.462% |
| UFP Technologies, Inc. | 70.19 Million USD | 96.615% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 629.17 Thousand USD | -277.635% |
| Tenon Medical, Inc. | 554 Thousand USD | -328.881% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 1.66 Million USD | -42.726% |
| AdaptHealth Corp. | 113.64 Million USD | 97.909% |
| Sintx Technologies, Inc. | 888 Thousand USD | -167.568% |
| NanoVibronix, Inc. | 2.73 Million USD | 13.031% |
| Quanterix Corporation | 22.36 Million USD | 89.376% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 14.84 Million USD | 83.997% |
| Pacific Biosciences of California, Inc. | 56.67 Million USD | 95.808% |
| TransMedics Group, Inc. | 44.23 Million USD | 94.629% |
| ReWalk Robotics Ltd. | 5.65 Million USD | 57.969% |
| NeuroMetrix, Inc. | 1.55 Million USD | -52.364% |
| Hyperfine, Inc. | 6.58 Million USD | 63.902% |
| Establishment Labs Holdings Inc. | 79.93 Million USD | 97.028% |
| Bone Biologics Corporation | -328.84 Thousand USD | 822.531% |
| AVITA Medical, Inc. | 3.12 Million USD | 23.881% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 29.87 Million USD | 92.047% |